Current Status of Poultry Recombinant Virus Vector Vaccine Development

Overview

Journal Vaccines (Basel)

Date 2024 Jun 27

PMID 38932359

Authors

Haoran Wang

Jiaxin Tian

Jing Zhao

Ye Zhao

Huiming Yang

Guozhong Zhang

Affiliations

Soon will be listed here.

Abstract

Inactivated and live attenuated vaccines are the mainstays of preventing viral poultry diseases. However, the development of recombinant DNA technology in recent years has enabled the generation of recombinant virus vector vaccines, which have the advantages of preventing multiple diseases simultaneously and simplifying the vaccination schedule. More importantly, some can induce a protective immune response in the presence of maternal antibodies and offer long-term immune protection. These advantages compensate for the shortcomings of traditional vaccines. This review describes the construction and characterization of primarily poultry vaccine vectors, including fowl poxvirus (FPV), fowl adenovirus (FAdV), Newcastle disease virus (NDV), Marek's disease virus (MDV), and herpesvirus of turkey (HVT). In addition, the pathogens targeted and the immunoprotective effect of different poultry recombinant virus vector vaccines are also presented. Finally, this review discusses the challenges in developing vector vaccines and proposes strategies for improving immune efficacy.

Citing Articles

Recombinant Marek's disease virus expressing VP1 and VP2 proteins provides robust immune protection against chicken infectious anemia virus.

Ge C, Lu H, Han J, Sun G, Li S, Lan X Front Microbiol. 2025; 15():1515415.

PMID: 39834361 PMC: 11743625. DOI: 10.3389/fmicb.2024.1515415.

Evaluation of Tissue Tropism and Horizontal Transmission of a Duck Enteritis Virus Vectored Vaccine in One-Day-Old Chicken.

Abdulrahim Y, You Y, Wang L, Bi Z, Xie L, Chen S Viruses. 2024; 16(11).

PMID: 39599796 PMC: 11598839. DOI: 10.3390/v16111681.

References

Tan L, Wen G, Yuan Y, Huang M, Sun Y, Liao Y . Development of a Recombinant Thermostable Newcastle Disease Virus (NDV) Vaccine Express Infectious Bronchitis Virus (IBV) Multiple Epitopes for Protecting against IBV and NDV Challenges. Vaccines (Basel). 2020; 8(4). PMC: 7712034. DOI: 10.3390/vaccines8040564. View

Zhao W, Hu H, Zsak L, Yu Q, Yang Z . Application of the ligation-independent cloning (LIC) method for rapid construction of a minigenome rescue system for Newcastle disease virus VG/GA strain. Plasmid. 2013; 70(3):314-20. DOI: 10.1016/j.plasmid.2013.07.005. View

Wilken L, Stelz S, Agac A, Sutter G, Prajeeth C, Rimmelzwaan G . Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines (Basel). 2023; 11(4). PMC: 10140942. DOI: 10.3390/vaccines11040714. View

Swayne D, Beck J, Mickle T . Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Dis. 1998; 41(4):910-22. View

Molouki A, Peeters B . Rescue of recombinant Newcastle disease virus: a short history of how it all started. Arch Virol. 2017; 162(7):1845-1854. DOI: 10.1007/s00705-017-3308-2. View

Wang Y, Sun Y, Tian Z, Shi X, Tong G, Liu S . Protection of chickens against infectious bronchitis by a recombinant fowlpox virus co-expressing IBV-S1 and chicken IFNgamma. Vaccine. 2009; 27(50):7046-52. DOI: 10.1016/j.vaccine.2009.09.065. View

Zai X, Shi B, Shao H, Qian K, Ye J, Yao Y . Recombinant Turkey Herpesvirus Expressing H9N2 HA Gene at the HVT005/006 Site Induces Better Protection Than That at the HVT029/031 Site. Viruses. 2022; 14(11). PMC: 9698400. DOI: 10.3390/v14112495. View

Veits J, Luschow D, Kindermann K, Werner O, Teifke J, Mettenleiter T . Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J Gen Virol. 2003; 84(Pt 12):3343-3352. DOI: 10.1099/vir.0.19570-0. View

Peeters B, de Leeuw O . A single-plasmid reverse genetics system for the rescue of non-segmented negative-strand RNA viruses from cloned full-length cDNA. J Virol Methods. 2017; 248:187-190. DOI: 10.1016/j.jviromet.2017.07.008. View

10.

Sonoda K, Sakaguchi M, Okamura H, Yokogawa K, Tokunaga E, Tokiyoshi S . Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies. J Virol. 2000; 74(7):3217-26. PMC: 111822. DOI: 10.1128/jvi.74.7.3217-3226.2000. View

11.

Britton P, Green P, Kottier S, Mawditt K, Penzes Z, Cavanagh D . Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus. J Gen Virol. 1996; 77 ( Pt 5):963-7. DOI: 10.1099/0022-1317-77-5-963. View

12.

Singh P, Schnitzlein W, Tripathy D . Construction and characterization of a fowlpox virus field isolate whose genome lacks reticuloendotheliosis provirus nucleotide sequences. Avian Dis. 2005; 49(3):401-8. DOI: 10.1637/7340-020705R.1. View

13.

Zhao H, Peeters B . Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication. J Gen Virol. 2003; 84(Pt 4):781-788. DOI: 10.1099/vir.0.18884-0. View

14.

Tang N, Zhang Y, Sadigh Y, Moffat K, Shen Z, Nair V . Generation of A Triple Insert Live Avian Herpesvirus Vectored Vaccine Using CRISPR/Cas9-Based Gene Editing. Vaccines (Basel). 2020; 8(1). PMC: 7157232. DOI: 10.3390/vaccines8010097. View

15.

Esaki M, Noland L, Eddins T, Godoy A, Saeki S, Saitoh S . Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens. Avian Dis. 2014; 57(2):192-8. DOI: 10.1637/10383-092412-Reg.1. View

16.

Rafique S, Jabeen Z, Pervaiz T, Rashid F, Luo S, Xie L . Avian infectious bronchitis virus (AIBV) review by continent. Front Cell Infect Microbiol. 2024; 14:1325346. PMC: 10875066. DOI: 10.3389/fcimb.2024.1325346. View

17.

Tsukamoto K, Saito S, Saeki S, Sato T, Tanimura N, Isobe T . Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens. J Virol. 2002; 76(11):5637-45. PMC: 137028. DOI: 10.1128/jvi.76.11.5637-5645.2002. View

18.

Okoli A, Okeke M, Tryland M, Moens U . CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development. Viruses. 2018; 10(1). PMC: 5795463. DOI: 10.3390/v10010050. View

19.

Ackford J, Corredor J, Pei Y, Krell P, Bedecarrats G, Nagy E . Foreign gene expression and induction of antibody response by recombinant fowl adenovirus-9-based vectors with exogenous promoters. Vaccine. 2017; 35(37):4974-4982. DOI: 10.1016/j.vaccine.2017.07.087. View

20.

Bentley K, Armesto M, Britton P . Infectious Bronchitis Virus as a Vector for the Expression of Heterologous Genes. PLoS One. 2013; 8(6):e67875. PMC: 3694013. DOI: 10.1371/journal.pone.0067875. View